Evidence map›Paper›PMID 36351761›Full record

ReviewJournal of the American Society of Nephrology : JASN2022

Artificial Intelligence You Can Trust: What Matters Beyond Performance When Applying Artificial Intelligence to Renal Histopathology?

John O O Ayorinde, Federica Citterio, Matteo Landrò, Elia Peruzzo, Tuba Islam, Simon Tilley, Geoffrey Taylor, Victoria Bardsley, Pietro Liò, Alex Samoshkin and 1 more

Abstract readReview
In one paragraph

Review in Journal of the American Society of Nephrology : JASN, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Artificial Intelligence Advances in Transplant Pathology.Bioengineering (Basel, Switzerland) · 2023
    Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

John O O AyorindeDepartment of Surgery, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.ORCID 0000-0001-6603-0139
Federica CitterioSAS Institute Inc., Cary, NC.
Matteo LandròSAS Institute Inc., Cary, NC.
Elia PeruzzoSAS Institute Inc., Cary, NC.
Tuba IslamSAS Institute Inc., Cary, NC.
Simon TilleySAS Institute Inc., Cary, NC.
Geoffrey TaylorSAS Institute Inc., Cary, NC.
Victoria BardsleyDepartment of Histopathology, Addenbrooke's Hospital, Cambridge, United Kingdom.
Pietro LiòDepartment of Computer Science and Technology, University of Cambridge, Cambridge, United Kingdom.
Alex SamoshkinOffice for Translational Research, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Gavin J PettigrewDepartment of Surgery, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.

Funding

Medical Research Council A094757
6 · The paper itself

Abstract

Although still in its infancy, artificial intelligence (AI) analysis of kidney biopsy images is anticipated to become an integral aspect of renal histopathology. As these systems are developed, the focus will understandably be on developing ever more accurate models, but successful translation to the clinic will also depend upon other characteristics of the system.In the extreme, deployment of highly performant but "black box" AI is fraught with risk, and high-profile errors could damage future trust in the technology. Furthermore, a major factor determining whether new systems are adopted in clinical settings is whether they are "trusted" by clinicians. Key to unlocking trust will be designing platforms optimized for intuitive human-AI interactions and ensuring that, where judgment is required to resolve ambiguous areas of assessment, the workings of the AI image classifier are understandable to the human observer. Therefore, determining the optimal design for AI systems depends on factors beyond performance, with considerations of goals, interpretability, and safety constraining many design and engineering choices.In this article, we explore challenges that arise in the application of AI to renal histopathology, and consider areas where choices around model architecture, training strategy, and workflow design may be influenced by factors beyond the final performance metrics of the system.

Indexed as

Artificial IntelligenceTrustHumansKidneyAIarteriosclerosisartificial intelligenceglomerulosclerosisinterstitial fibrosiskidney biopsyrenal fibrosisrenal pathologyrenal transplantationtransplant pathology

Identifiers

PMID36351761
PMCPMC9731632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.